Real American Capital Corp. (OTCPK:RLAB) acquired M2MMA from Institute of Biomedical Research Corp. (OTCPK:MRES) on January 30, 2024. As per the terms, the consideration will be paid in shares, resulting in a change of control of Real American Capital Corporation.

Real American Capital Corp. (OTCPK:RLAB) completed the acquisition of M2MMA from Institute of Biomedical Research Corp. (OTCPK:MRES) on January 30, 2024.